SCHEMBL4931518

SCHEMBL4931518

Cc1cc(=O)oc2cc(-c3ccc(N)c(CCO)c3)ccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.52
▸ KDM4E B2RXH2 8/20 0.52
▸ HPGD P15428 8/20 0.52
▸ HSD17B10 Q99714 8/20 0.52
▸ GLA P06280 5/20 0.52
▸ CA9 Q16790 5/20 0.52
▸ GAA P10253 4/20 0.52
▸ CA12 O43570 4/20 0.52
▸ CASP1 P29466 3/20 0.52
▸ CASP7 P55210 3/20 0.52
▸ CA1 P00915 3/20 0.52
▸ MCL1 Q07820 3/20 0.49
▸ MAOB P27338 2/20 0.49
▸ AKR1B1 P15121 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ UGT1A1 P22309 1/20 0.49
▸ KDR P35968 1/20 0.49
▸ HSD17B3 P37058 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4929995 0.77 ALDH1A1 (0.76) ALDH1A1KDM4EHPGDHSD17B10GLA
SCHEMBL4929370 0.76 CA9 (0.61) ALDH1A1KDM4EHPGDHSD17B10GLA
SCHEMBL4926543 0.75 CA12 (0.61) ALDH1A1KDM4EHPGDHSD17B10GLA
SCHEMBL9230035 0.75 MCL1 (0.62) ALDH1A1KDM4EHPGDHSD17B10GLA
SCHEMBL2770653 0.74 CYP3A4 (0.44) ALDH1A1KDM4EHPGDHSD17B10GAA
SCHEMBL19427475 0.73 ALDH1A1 (0.60) ALDH1A1KDM4EHPGDHSD17B10GLA
SCHEMBL15842699 0.72 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDHSD17B10GLA
SCHEMBL4929255 0.72 HSD17B10 (0.55) ALDH1A1KDM4EHPGDHSD17B10GLA
SCHEMBL4925486 0.70 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDHSD17B10GLA
SCHEMBL29645144 0.70 ALDH1A1 (1.00) ALDH1A1KDM4EHPGDHSD17B10GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) MAOA, MAOB, COMT ALDH1A1 181/4885KDM4E 1183/4885HPGD 296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback